Preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients. Period of performance 7/1/2016 - 6/30/2021

Ended Awarded Last action

Contract number
HHSN261201600022I
Awardee
Awarding agency
Task orders
7 $691,527 obligated

Award facts

Combined order value
  • $691,527 Current, with exercised options
  • $851,434 Potential, with all options
Last date to order 100% complete
IDV ceiling 7% used
$9,900,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Title: pharmacokinetic and oral bioavailability studies in rats. Period of performance: 4/16/2021 to 4/15/2022… 75N91021F00001 National Cancer Institute (NIH) $103,177
Torfp g: to#6 "analytical support and PK sample analysis for preclinical pharmacology studies" period of performance… 75N91019F00130 National Cancer Institute (NIH) $59,335
Pharmacokinetic studies with selected anticancer compounds in NSG mice period of performance 09/13/2019 - 09/12/2024… 75N91019F00129 National Cancer Institute (NIH) $208,940
Title: "determination of 5-fluoro-2'-deoxycytidine (fdcyd), selected downstream metabolites (fdurd, FU), and… HHSN26100004 National Cancer Institute (NIH) $27,605
Special studies/analysis- chemical/biological HHSN26100003 National Cancer Institute (NIH) $17,757
Title: determination of LMP744 (NSC 706744) levels in human plasma and urine samples from an NCI phase i trial.POP… HHSN26100002 National Cancer Institute (NIH) $274,027
Kick-off meeting preclinical pharmacokinetic & pharmacology evaluations of agents being developed for cancer… HHSN26100001 National Cancer Institute (NIH) $685

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201600022I?

HHSN261201600022I was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Cancer Institute (National Institutes of Health) on July 1, 2016.

How much is contract HHSN261201600022I worth?

Orders under HHSN261201600022I have obligated $691,527. Their combined potential value, with all options, is $851,434. HHSN261201600022I's own ceiling is $9,900,000.

How many orders have been placed under contract HHSN261201600022I?

7 orders have been placed under HHSN261201600022I, the latest on April 16, 2021.

Who can order from contract HHSN261201600022I?

HHSN261201600022I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201600022I part of a contract vehicle?

Yes. HHSN261201600022I is part of Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.

Was contract HHSN261201600022I competed?

The extent of competition for HHSN261201600022I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login